HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced external counterpulsation is an effective treatment for Syndrome X.

Abstract
Enhanced external counterpulsation (EECP) was used to treat 30 patients with refractory angina due to cardiac Syndrome X, with an initial improvement in CCS angina class (3.57 to 1.43; p<0.001) and regional ischemia in all treated patients. At a mean of 11.9 months follow-up, 87% of patients had sustained improvement in angina and were without MACE. EECP, by improving endothelial function, may be an effective and durable treatment for this often difficult to treat problem.
AuthorsKenneth D Kronhaus, William E Lawson
JournalInternational journal of cardiology (Int J Cardiol) Vol. 135 Issue 2 Pg. 256-7 (Jun 26 2009) ISSN: 1874-1754 [Electronic] Netherlands
PMID18590931 (Publication Type: Clinical Trial, Letter)
Topics
  • Aged
  • Counterpulsation
  • Female
  • Humans
  • Male
  • Microvascular Angina (surgery)
  • Middle Aged
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: